Question 1

Does Goldman Sachs Group own SMMT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs Group holds 4,513,399 shares of SMMT (Summit Therapeutics), worth $65.8M.

Question 2

How many shares of SMMT does Goldman Sachs Group own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group holds 4,513,399 shares of SMMT (Summit Therapeutics).

Question 3

What is Goldman Sachs Group's SMMT position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group's SMMT position is worth $65.8M.

Question 4

Is Goldman Sachs Group buying or selling SMMT?

Accepted Answer

In Q2 2026, Goldman Sachs Group increased its SMMT position from 310,728 to 4,513,399 shares.

Question 5

When did Goldman Sachs Group first buy SMMT?

Accepted Answer

Goldman Sachs Group already held SMMT in its Q2 2022 13F, the earliest on record, and has listed it in 17 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	4.5M	+1352.5%	$65.8M	0.0%	$14.57	48
2026-Q1	Decreased	310,728	-36.0%	$5.9M	0.0%	$15.11	0
2025-Q4	Decreased	485,566	-2.4%	$8.5M	0.0%	$17.49	0
2025-Q3	Increased	497,547	+64.0%	$10.3M	0.0%	$21.16	40
2025-Q2	Decreased	303,426	-47.0%	$6.5M	0.0%	$20.60	0
2025-Q1	Decreased	572,791	-37.1%	$11M	0.0%	$20.32	0
2024-Q4	Increased	910,002	+83.7%	$16.2M	0.0%	$17.85	44
2024-Q3	Increased	495,355	+9.1%	$10.8M	0.0%	$21.90	30